kabutan

C.I. MEDICAL, The Current Fiscal Year Ordinary Profit Revised Upward by 6%

Tue May 13, 2025 3:30 pm JST Earnings

3540 C.I. MEDICAL CO.,LTD. 【J-GAAP】

Earnings Report

C.I. MEDICAL CO.,LTD. <3540> [TSE Std] announced its financial results after the market closed on May 13th (15:30). The consolidated ordinary profit for the first quarter of the fiscal year ending December 2025 (January to March) expanded 0.8 billion yen, an increase 98.0% compared to the same period last year.

In addition, the full-year consolidated ordinary profit has been revised upward 6.4%, from the previous forecast of 4.26 billion yen to 4.54 billion yen (compared to 2.62 billion yen in the previous period), increasing the growth rate from 62.8% to 73.2%.

At the same time, the January to June period (1H) consolidated ordinary profit has been revised upward 11.1%, from the previous forecast of 1.91 billion yen to 2.13 billion yen (compared to 0.97 billion yen in the same period of the previous year), increasing the growth rate from 97.4% to 2.2 times.

In the most recent three-month period, from January to March (1Q), the operating profit margin remained almost flat, changing from 3.4% in the same period last year to 3.1%.

Kabutan News

Actual Results

Accumulated Results 1st Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Mar, 2023 10,999 786 851 521 10.4 43.6 May 9, 2023 J-GAAP
Jan - Mar, 2024 11,946 407 407 247 5.0 41.9 May 14, 2024 J-GAAP
Jan - Mar, 2025 22,657 708 806 1,367 27.4 37.8 May 13, 2025 J-GAAP
YoY +89.7% +74.0% +98.0% +453.4% +452.5%

Guidance Update

First Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 Prev 46,114 1,842 1,917 1,598 32.0 － Feb 12, 2025 J-GAAP
Jan - Jun, 2025 New 46,550 2,020 2,130 2,400 48.0 － May 13, 2025 J-GAAP
Revision Rate +0.9% +9.7% +11.1% +50.2% +50.2%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2025 Prev 95,000 4,135 4,268 3,128 62.6 － Feb 12, 2025 J-GAAP
Dec, 2025 New 100,000 4,380 4,540 4,000 80.0 － May 13, 2025 J-GAAP
Revision Rate +5.3% +5.9% +6.4% +27.9% +27.9%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2024 24,316 983 971 577 11.6 0 Aug 13, 2024 J-GAAP
Jan - Jun, 2025 Guidance 46,550 2,020 2,130 2,400 48.0 － May 13, 2025 J-GAAP
YoY +91.4% +105.5% +119.4% +315.9% +315.6%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 45,628 2,989 3,295 2,082 41.7 5.04 Feb 13, 2024 J-GAAP
Dec, 2024 67,493 2,493 2,621 6,266 125.3 12.53 Feb 12, 2025 J-GAAP
Dec, 2025 Guidance 100,000 4,380 4,540 4,000 80.0 － May 13, 2025 J-GAAP
YoY +48.2% +75.7% +73.2% -36.2% -36.2%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 11,946 407 407 247 5.0 3.4 May 14, 2024 J-GAAP
Apr - Jun, 2024 12,370 576 564 330 6.6 4.7 Aug 13, 2024 J-GAAP
Jul - Sep, 2024 20,932 125 314 4,760 95.2 0.6 Nov 12, 2024 J-GAAP
Oct - Dec, 2024 22,245 1,385 1,336 929 18.6 6.2 Feb 12, 2025 J-GAAP
Jan - Mar, 2025 22,657 708 806 1,367 27.4 3.1 May 13, 2025 J-GAAP
YoY +89.7% +74.0% +98.0% +453.4% +452.5%

Related Articles